By the way, although the BALB/c nude mice we used in the study are immunodeficient, CCL20 can still promote CRC tumorigenesis via non-immune pathways such as CCR6/PI3K/ERK-AKT signaling. The gene discussed is CCL20; the disease is colorectal carcinoma.